BRWM
ICPT

B. Riley Wealth Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

B. Riley Wealth Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-270
Closed -$63K – 1176
2014
Q2 		$63K Sell
270
-5
-2% -$1.32K 0.04% 425
2014
Q1 		$91K Buy
+275
New +$92.8K 0.07% 332

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

B. Riley Wealth Management's ICPT Position: Q3 2014 in Review

B. Riley Wealth Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2014, closing a stake of 270 shares — an estimated $63K sold.

B. Riley Wealth Management first reported a position in ICPT in Q1 2014 and held it in 2 quarters. The position peaked at $91K in Q1 2014. 181 funds tracked by Wall St. Rank hold ICPT as of Q3 2014.

  • B. Riley Wealth Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Management sold 270 Intercept Pharmaceuticals, Inc. shares in Q3 2014, an estimated $63K.
  • B. Riley Wealth Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • B. Riley Wealth Management's Intercept Pharmaceuticals, Inc. position peaked at $91K in Q1 2014.
  • 181 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2014.

Based on B. Riley Wealth Management's 13F filing for Q3 2014, filed 3 Oct 2014.